β-Lapachone
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


β-Lapachone
Description:
β-Lapachone (ARQ-501; NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression.Product Name Alternative:
ARQ-501; NSC-26326UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Apoptosis; Autophagy; Indoleamine 2,3-Dioxygenase (IDO) ; TopoisomeraseType:
Natural ProductsRelated Pathways:
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/ProteaseApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/_beta_-Lapachone.htmlPurity:
99.96Solubility:
DMSO : 25 mg/mL (ultrasonic) |Ethanol : 8.33 mg/mL (ultrasonic)Smiles:
O=C (C1=C2OC (C) (C) CC1) C (C3=C2C=CC=C3) =OMolecular Formula:
C15H14O3Molecular Weight:
242.27Precautions:
H302, H315, H319, H335References & Citations:
[1]Li CJ, et al. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem. 1993 Oct 25;268 (30) :22463-8.|[2]Vanni A, et al. DNA damage and cytotoxicity induced by beta-lapachone: relation to poly (ADP-ribose) polymerase inhibition. Mutat Res. 1998 Jun 5;401 (1-2) :55-63.|[3]Kim TW, et al. β-Lapachone enhances Mre11-Rad50-Nbs1 complex expression in cisplatin-induced nephrotoxicity. Pharmacol Rep. 2016 Feb;68 (1) :27-31.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
Phase 2Isoform:
Topo ICAS Number:
4707-32-8
